Randomized, double-blind, placebo-controlled, phase I study of the safety and pharmacokinetics of namilumab in healthy Japanese and Caucasian men
Shingo Tanaka1, Sayaka Harada1, Naoto Hiramatsu1, Ryou Nakaya1, Masaki Kawamura2
1 Takeda Pharmaceutical Company Ltd., Osaka, and 2 Takeda Pharmaceutical Company Ltd., Tokyo, Japan
| Shopping Overview | ||||
| Type | Qtty | Discount | VAT | Price |
| Your basket is empty | ||||
| View Cart | ||||